KOSDAQ-listed ROKIT Healthcare was strong early on the 8th. Buying is seen as being driven by news that it signed a strategic partnership agreement with the No. 1 group in China's medical device market.
As of 9:39 a.m. that day, ROKIT Healthcare was trading at 69,300 won, up 5,800 won (9.13%) from the previous session.
ROKIT Healthcare, an artificial intelligence (AI) organ regeneration platform specialist, said before the market opened that day that it signed a strategic partnership agreement with WEGO Group to commercialize an AI hyper-personalized organ regeneration platform.
WEGO Group is China's top medical device healthcare company, headquartered in Shandong province, with a nationwide hospital network and logistics infrastructure.
A ROKIT Healthcare official said, "With President Lee Jae-myung's state visit to China opening the sluice gates for Korea-China economic cooperation, ROKIT Healthcare joined hands with China's top medical device group to preempt the 1.4 trillion won Chinese skin regeneration market, emerging as one of the practical beneficiaries of this state visit."